CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale Director sold 5,539 shares at $40.00 ($221,560)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 14,461 shares at an average $40.80 ($590,042)
- 4 Open-market sale Chief Executive Officer sold 36,149 shares at an average $40.47 ($1,462,808)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 11,650 shares at an average $36.83 ($429,085)
- 4 Open-market sale Director sold 38,107 shares at an average $36.96 ($1,408,612)
- 4 Open-market sale Chief Executive Officer sold 31,989 shares at an average $39.39 ($1,260,073)
- 4 Open-market sale Director sold 36,892 shares at an average $39.89 ($1,471,756)
- 4 Open-market sale Chief Executive Officer sold 108,999 shares at an average $40.91 ($4,459,330)
- 4 Open-market sale Director sold 38,351 shares at an average $38.19 ($1,464,793)
- 4 Open-market sale Chief Executive Officer sold 64,963 shares at an average $40.55 ($2,634,011)
- 4 Open-market sale Director sold 93,750 shares at $32.00 ($3,000,000)
- 4 Open-market buy Director bought 30,000 shares at $32.00 ($960,000)
- 4 Open-market buy Director bought 1,760,495 shares at $32.00 ($56,335,840)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 27 of 29 · 580 filings